Martins et al; “The preclinical pharmacokinetics of Tolinapant—A dual cIAP1/XIAP antagonist with in vivo efficacy” Pharmacol Res Perspect, 2024

25 October 2024/in 2024, 2024, ASTX660 – Dual IAP Antagonist, Products, Publications

Martins et al; “The preclinical pharmacokinetics of Tolinapant—A dual cIAP1/XIAP antagonist with in vivo efficacy” Pharmacol Res Perspect, 2024

https://doi.org/10.1002/prp2.70030

https://astx.com/wp-content/uploads/2023/12/New_Home_Logo_RGB.svg 0 0 webadmin https://astx.com/wp-content/uploads/2023/12/New_Home_Logo_RGB.svg webadmin2024-10-25 11:53:222024-11-19 11:55:27Martins et al; “The preclinical pharmacokinetics of Tolinapant—A dual cIAP1/XIAP antagonist with in vivo efficacy” Pharmacol Res Perspect, 2024

Useful links

Home
Sitemap
Privacy Policy
Terms of Use
Legal

Member of the Otsuka Group

A selection of photos on this website
is courtesy of Valerio Berdini

2024 ENA (poster): Pulsatile Induction of the p53 Pathway by MDM2 Antagonist...2023 AD/PD (poster): Development of a Cellular Platform to Study Lysosomal Functions...

Scroll to top

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.Ok